Astrana Health (NASDAQ:ASTH) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Astrana Health (NASDAQ:ASTH) from a hold rating to a buy rating in a research note released on Saturday morning.

ASTH has been the subject of a number of other research reports. BTIG Research lifted their price target on Astrana Health from $50.00 to $65.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Needham & Company LLC upped their price objective on shares of Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. TD Cowen raised their target price on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Weiss Ratings raised shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 1st. Finally, Barclays lifted their target price on shares of Astrana Health from $50.00 to $53.00 and gave the company an “overweight” rating in a research report on Friday. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $49.43.

Astrana Health Price Performance

NASDAQ:ASTH opened at $37.47 on Friday. Astrana Health has a 52-week low of $18.08 and a 52-week high of $51.60. The stock has a fifty day moving average of $41.36 and a 200 day moving average of $32.58. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.35 and a current ratio of 1.23. The firm has a market capitalization of $2.09 billion, a price-to-earnings ratio of 45.70 and a beta of 0.87.

Hedge Funds Weigh In On Astrana Health

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Signaturefd LLC raised its holdings in shares of Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after buying an additional 388 shares in the last quarter. Strs Ohio purchased a new stake in Astrana Health in the fourth quarter worth approximately $40,000. Tower Research Capital LLC TRC boosted its stake in Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after buying an additional 3,517 shares in the last quarter. State of Wyoming bought a new position in Astrana Health during the second quarter valued at approximately $132,000. Finally, Los Angeles Capital Management LLC bought a new position in Astrana Health during the fourth quarter valued at approximately $228,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.